Home/Filings/4/0001140361-20-027399
4//SEC Filing

Rome Michael E 4

Accession 0001140361-20-027399

CIK 0001797768other

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 6:30 PM ET

Size

5.1 KB

Accession

0001140361-20-027399

Insider Transaction Report

Form 4
Period: 2020-12-02
Transactions
  • Award

    Stock Option (right to buy)

    2020-12-02+40,50140,501 total
    Exercise: $20.00Exp: 2030-12-02Common Stock (40,501 underlying)
Footnotes (1)
  • [F1]The Option vests and becomes exercisable over time at the following rate: 1/36th of the total number of shares subject to the Option shall vest monthly in equal installments over three years commencing on the one-month anniversary of December 2, 2020, the Vesting Commencement Date, and each month thereafter on the same day of the month as the Vesting Commencement Date.

Issuer

Kinnate Biopharma Inc.

CIK 0001797768

Entity typeother

Related Parties

1
  • filerCIK 0001820818

Filing Metadata

Form type
4
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 6:30 PM ET
Size
5.1 KB